KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Thermo Fisher Scientific (TMO) Net Margin (2016 - 2026)

Thermo Fisher Scientific filings provide 18 years of Net Margin readings, the most recent being 15.06% for Q1 2026.

  • On a quarterly basis, Net Margin rose 52.0% to 15.06% in Q1 2026 year-over-year; TTM through Mar 2026 was 15.3%, a 11.0% increase, with the full-year FY2025 number at 15.16%, up 38.0% from a year prior.
  • Net Margin hit 15.06% in Q1 2026 for Thermo Fisher Scientific, down from 16.32% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 18.74% in Q2 2022 to a low of 12.04% in Q2 2023.
  • Median Net Margin over the past 5 years was 14.97% (2023), compared with a mean of 14.84%.
  • The widest YoY moves for Net Margin: up 222bps in 2023, down -671bps in 2023.
  • Thermo Fisher Scientific's Net Margin stood at 13.76% in 2022, then rose by 9bps to 14.97% in 2023, then increased by 7bps to 16.06% in 2024, then grew by 2bps to 16.32% in 2025, then dropped by -8bps to 15.06% in 2026.
  • The last three reported values for Net Margin were 15.06% (Q1 2026), 16.32% (Q4 2025), and 14.49% (Q3 2025) per Business Quant data.